Data is not available at this time.
Tohoku Chemical Co., Ltd. operates as a specialized trading company in Japan, focusing on the distribution of chemicals, reagents, and related equipment across multiple industries. Its core revenue streams stem from pesticides, food additives, industrial chemicals, and clinical diagnostic reagents, catering to agriculture, healthcare, and manufacturing sectors. The company serves as a critical intermediary, supplying high-purity reagents and analytical tools for research, medical diagnostics, and industrial applications. Tohoku Chemical has established a niche presence by integrating distribution with technical support, ensuring reliability for clients in regulated industries. Its diversified product portfolio, spanning agricultural materials, medical devices, and hygiene products, positions it as a versatile supplier in Japan’s specialty chemicals market. While not a dominant player, its regional focus and long-standing relationships with manufacturers and end-users provide stability in a competitive landscape. The company’s involvement in cultivation and sale of flowers, alongside its core chemical distribution, adds a unique but minor revenue diversification.
Tohoku Chemical reported revenue of ¥32.2 billion for the period, with net income of ¥237 million, reflecting thin margins typical of trading companies. Operating cash flow was negative at ¥-1.04 billion, likely due to working capital pressures, while capital expenditures remained minimal at ¥-64 million. The company’s asset-light model emphasizes distribution efficiency, but profitability is constrained by competitive pricing and operational costs.
The company’s diluted EPS was negligible, indicating limited earnings power relative to its revenue base. Capital efficiency appears modest, with no significant investments in production assets. Its reliance on trading margins and technical services suggests steady but low-return operations, typical of intermediaries in the chemical distribution sector.
Tohoku Chemical maintains a conservative balance sheet, with ¥764 million in cash and equivalents against ¥783 million in total debt, indicating near-neutral liquidity. The absence of excessive leverage aligns with its low-risk trading model, though the negative operating cash flow warrants monitoring for sustained working capital needs.
Growth trends appear muted, with no explicit guidance on expansion. The company pays a dividend of ¥105 per share, signaling a commitment to shareholder returns despite modest earnings. Its focus on stable, niche markets limits cyclical exposure but also caps high-growth opportunities.
With a market cap of ¥3.5 billion and a beta of 0.21, the stock is priced as a low-volatility, small-cap niche player. The absence of significant earnings or growth catalysts suggests market expectations remain subdued, reflecting its regional and industry-specific constraints.
Tohoku Chemical’s strengths lie in its diversified product range and entrenched regional relationships. However, its outlook is tempered by limited scalability and reliance on Japan’s stagnant industrial demand. Strategic shifts toward higher-margin services or international expansion could enhance long-term prospects, but execution risks persist.
Company description, financial data from disclosed filings (FY ending 2024-09-30), and market data from exchange sources.
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |